Loading
Latest filing published 19 Oct 2020 for Cannara Biotech Inc. (formerly, Dunbar Capital Corp.), €8,233.
No signal scores available.
Lennie Ryer appears in our data through filings on Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) shares, published by SEDI. Over a trading history stretching from 13 March 2019 to 15 October 2020, the count stands at 4 filings.
Purchases make up the whole of the open-market record (4 purchases, €20k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2020: 3 purchases and no sales on the market.
In size, the median ticket on the buying side is €4,292.
The newest entry dates from 19 October 2020: an open-market purchase of €8,233, in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). Filings reach the SEDI feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations